The bioavailability of psychoactive agents is intimately related to their therapeutic efficacy, and is affected by several variables, each of which requires careful consideration.
KeywordsNeuroleptic Drug Delirium Tremens Endogenous Depression Formal Thought Disorder Serum Lithium Level
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- AMA Department of Drugs. AMA Drug Evaluations, PSG Pub. Co., Acton, Mass. (1977).Google Scholar
- Baldessarini, R. J. Chemotherapy in Psychiatry. Harvard, Cambridge (1977).Google Scholar
- Barchas, J. D., Berger, P. A., Ciaranello, R. D., and Elliott, G. R. Psychopharmacology from Theory to Practice. Oxford, New York (1977).Google Scholar
- Jefferson, J. W., and Greist, J. H. Primer of Lithium Therapy. Williams and Wilkins, Baltimore (1977).Google Scholar
- Johnson, F. N. (ed.). Lithium Research and Therapy. Academic, New York (1975).Google Scholar
- Kornetzky, C. Pharmacology: Drugs Affecting Behavior. Wiley, New York (1976).Google Scholar
- Lipton, M. A., DiMascio, A., and Killam, K. F. (eds.). Psychopharmacology: A Generation of Progress. Raven, New York (1978).Google Scholar
- Sellers, E. M. Clinical Pharmacology of Psychoactive Drugs. Addiction Res. Found., Ontario (1975).Google Scholar
- Shader, R. I. (ed). Manual of Psychiatric Therapeutics. Little, Brown, Boston (1975).Google Scholar
- Van Praag, H. M. Psychotropic Drugs: A Guide for the Practitioner. Brunner/Mazel, New York (1978).Google Scholar
© Spectrum Publications 1982